{"id":"3ad2933f-79a5-41b9-9b25-5269c7923514","feedVisibility":"normal","congress":119,"billType":"s","billNumber":1906,"title":"Innovative FEED Act of 2025","displayTitle":"《2025年创新饲料增强与经济发展法案》","abstract":"《2025年创新饲料增强与经济发展法案》该法案规定对动物技术性饲料添加物按食品添加剂进行监管。该法案将“动物技术性饲料添加物”定义为添加到动物食物或饮用水中、仅影响动物胃肠道，且旨在影响动物消化副产品、减少食源性病原体或改变动物胃肠道微生物群的物质。该定义不包括用于治疗或预防动物疾病的物质、激素或动物药品的有效成分。动物技术性饲料添加物的标签须注明该物质不得用于治疗或预防动物疾病。","displaySummary":"<p><strong>YVN Summary</strong></p>\n\n<p>目前，添加到动物饲料中用于影响肠道微生物群或减少沙门氏菌等食源性病原体的物质被归类为药物进行监管——这一审批流程可能耗时数年、耗资数百万美元。该法案将创设一个名为「动物饲料促生长物质」的新类别，将其作为食品添加剂而非药物进行监管，从而走上一条通过FDA更快获批的通道。这些物质须仅在动物消化道内发挥作用，不得用于疾病的诊断、治愈或治疗。此次调整有望加速创新饲料产品进入畜牧业市场，同时仍须经过FDA的安全审查。</p>","status":"COMMITTEE_CONSIDERATION","topics":["ENVIRONMENT","AGRICULTURE","GOVERNMENT_OPERATIONS"],"introducedAt":"2025-05-22T00:00:00+00:00","latestActionAt":"2025-05-22T00:00:00+00:00","congressGovUrl":"https://www.congress.gov/bill/119th-congress/senate-bill/1906","accountabilityFlags":{"corporate_benefits":["↑ 动物技术饲料添加剂审批途径 — 从FDA新动物药物审查转至食品添加剂轨道","↓ 牲畜养殖者饲料添加剂的监管成本和上市时间 — 通过新途径减少"],"transparency_accountability":["↑ 强制性产品标签声明 — 涵盖物质须标注'不用于诊断、治愈、缓解、治疗或预防疾病'","↑ 缺失标签的假冒标识后果 — 未标注规定声明的物质视为假冒标识食品"]},"tldr":"为促进肠道健康的动物饲料添加剂设立更快的FDA审批通道，将其按食品而非药品进行监管。","summaryStandard":null,"flagExplainers":{},"flagValence":{},"needsResummary":false,"displaySummaryHtml":null,"rawStatusText":"Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.","chamber":"SENATE","policyArea":"Health","legislativeSubjects":[],"lawStatus":null,"lawNumber":null,"latestActionText":"Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.","latestTextVersion":"Introduced in Senate","textVersionUsed":"Introduced in Senate","dateAdded":"2026-04-09T00:00:00+00:00","summarizedAt":"2026-04-09T00:00:00+00:00","recordId":"3ad2933f-79a5-41b9-9b25-5269c7923514","feedIdentityKey":"119/s/1906","websiteBillId":"S-1906","yourvoiceSummary":"目前，添加到动物饲料中用于影响肠道微生物群或减少沙门氏菌等食源性病原体的物质被归类为药物进行监管——这一审批流程可能耗时数年、耗资数百万美元。该法案将创设一个名为「动物饲料促生长物质」的新类别，将其作为食品添加剂而非药物进行监管，从而走上一条通过FDA更快获批的通道。这些物质须仅在动物消化道内发挥作用，不得用于疾病的诊断、治愈或治疗。此次调整有望加速创新饲料产品进入畜牧业市场，同时仍须经过FDA的安全审查。","updatedAt":"2026-10-25T04:06:47.535923+00:00"}